Breast cancer incidence and use of hormone therapy in Denmark 1978-2007. (Q44395164)

2 December 2017

title

Breast cancer incidence and use of hormone therapy in Denmark 1978-2007. (English)

1 reference

2 December 2017

0 references

My von Euler-Chelpin

1

1 reference

2 December 2017

publication date

20 November 2010

1 reference

2 December 2017

published in

Cancer Causes & Control

1 reference

2 December 2017

volume

22

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

181-187

1 reference

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Declining breast cancer incidence and decreased HRT use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

A decline in breast-cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Hormone replacement therapy in Denmark, 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Performance of clinical mammography: a nationwide study from Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Use of hormone replacement therapy by postmenopausal women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

Declines in breast cancer after the WHI: apparent impact of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9685-4

10.1007/S10552-010-9685-4

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference